Invesco Ltd.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
14,357
Total Value
320244803394
Accession Number
0000914208-25-000230
Form Type
13F-HR
Manager Name
Invesco Ltd.
Data Enrichment
96% identified
13,831 identified526 unidentified

Holdings

14,357 positions
Manager:
Search and click to pin securities to the top
Page 187 of 188
Pyxis Oncology, Inc.
Shares:
24805(-2.2%)
Value:
$24.3M(-38.6%)
ProQR Therapeutics N.V.
Shares:
18084(+52.1%)
Value:
$24.1M(-23.6%)
BRC Inc.
Shares:
11487(-7.7%)
Value:
$24.0M(-39.1%)
Skeena Resources Ltd
Shares:
2364(+0.0%)
Value:
$23.9M(+15.7%)
Eve Holding, Inc.
Shares:
7125(-37.7%)
Value:
$23.7M(-62.0%)
LiveOne, Inc.
Shares:
33503(+0.4%)
Value:
$23.4M(-52.3%)
Biomea Fusion, Inc.
Shares:
10959(-5.6%)
Value:
$23.3M(-48.2%)
FiscalNote Holdings, Inc.
Shares:
27081(-4.1%)
Value:
$21.9M(-27.6%)
Maiden Holdings, Ltd.
Shares:
37716(-3.6%)
Value:
$21.5M(-67.5%)
CASSAVA SCIENCES INC
Shares:
13117(+39.4%)
Value:
$19.7M(-11.4%)
Tevogen Bio Holdings Inc.
Shares:
17819(+4.7%)
Value:
$19.2M(+9.8%)
INOVIO PHARMACEUTICALS, INC.
Shares:
11779(-2.1%)
Value:
$19.2M(-12.8%)
GrowGeneration Corp.
Shares:
17608(-4.7%)
Value:
$19.0M(-39.1%)
Shattuck Labs, Inc.
Shares:
18908(+1.0%)
Value:
$18.0M(-20.7%)
Inozyme Pharma, Inc.
Shares:
19315(-3.0%)
Value:
$17.6M(-68.1%)
RENOVARO INC.
Shares:
29269(+0.7%)
Value:
$15.9M(-34.5%)
Adaptimmune Therapeutics PLC
Shares:
78031(+23.2%)
Value:
$15.4M(-54.9%)
Nautilus Biotechnology, Inc.
Shares:
17101(-4.4%)
Value:
$14.7M(-51.0%)
Werewolf Therapeutics, Inc.
Shares:
14232(-2.4%)
Value:
$13.8M(-35.9%)
X4 Pharmaceuticals, Inc
Shares:
58187(-6.3%)
Value:
$13.8M(-69.8%)